Loading clinical trials...
Loading clinical trials...
This study will evaluate the safety and blood levels of a new pediatric formulation of Famvir in children 1-12 years of age. In Part A, patients will receive a single dose of famciclovir (12.5 mg/kg) ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis Pharmaceuticals
NCT06474442 · Herpes Simplex Virus Type I Stromal Keratitis
NCT04065971 · Herpes Simplex
NCT05429346 · Genital Herpes Simplex, Maternal Morbidity, and more
NCT05432583 · Genital Herpes Simplex Type 2
NCT05468619 · Herpes Simplex
University of Alabama at Birmingham
Birmingham, Alabama
The Children's Hospital
Denver, Colorado
Children's Memorial Hospital
Chicago, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions